₹ 1.5 Cr
Volume transacted
9.5 K
stocks traded
Last Updated time: 05 Nov 13:57 PM
Strides Pharma Science Ltd
NSE: STAR
YEARLOW
₹ 467.4
Last updated on: Nov 04, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
04 Nov 2024 | 1553.65 | 1555.25 | 1580.2 | 1463.7 |
01 Nov 2024 | 1564.45 | 1555.4 | 1571.4 | 1555.4 |
31 Oct 2024 | 1555.3 | 1556.05 | 1562.85 | 1516 |
30 Oct 2024 | 1524.5 | 1494.1 | 1555 | 1494.1 |
29 Oct 2024 | 1494.1 | 1520.5 | 1529.95 | 1485.5 |
28 Oct 2024 | 1503.3 | 1569.95 | 1569.95 | 1476.15 |
25 Oct 2024 | 1509.65 | 1578.5 | 1599.7 | 1496.85 |
24 Oct 2024 | 1534.65 | 1527.55 | 1620 | 1526.85 |
23 Oct 2024 | 1558.7 | 1526 | 1578.5 | 1518.9 |
22 Oct 2024 | 1552.8 | 1659 | 1670 | 1525.25 |
Date | Price |
---|---|
04 Nov 2024 | 1553.65 |
01 Nov 2024 | 1564.45 |
31 Oct 2024 | 1555.3 |
30 Oct 2024 | 1524.5 |
29 Oct 2024 | 1494.1 |
28 Oct 2024 | 1503.3 |
25 Oct 2024 | 1509.65 |
24 Oct 2024 | 1534.65 |
23 Oct 2024 | 1558.7 |
22 Oct 2024 | 1552.8 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Strides Pharma Science Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Strides Pharma Science Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Strides Pharma Global, Singapore to acquire balance 30% stake in Strides Switzerland
Strides Pharma Global, Singapore (SPG), a wholly owned step-down subsidiary of Strides Pha...
25 Oct 202419:12
Strides Pharma reports turnaround Q2 numbers
Revenue from operations stood at Rs 1201.1 crore in the quarter ended September 2024, regi...
24 Oct 202414:48
Strides Pharma Science to declare Quarterly Result
Strides Pharma Science will hold a meeting of the Board of Directors of the Company on 24 ...
19 Oct 202410:05
OneSource Specialty Pharma receives pre-money equity valuation of USD 1.65 bn
Strides Pharma Science (Strides) today announced that its associate company, OneSource Spe...
16 Oct 202409:44
Strides Pharma hits record high after arm gets Rs 801 cr fund commitments
The fundraise is being led by HBM Healthcare Investments and associated investors, with th...
16 Oct 202411:41
Strides receives USFDA approval for Fluoxetine Tabs 60 mg
Strides Pharma Science announced that its step-down wholly owned subsidiary, Strides Pharm...
16 Sep 202415:22
FAQs for 52 Week Low of Strides Pharma Science Ltd
Why is it important to track the 52-week low of Strides Pharma Science Ltd stocks?
What factors can lead to Strides Pharma Science Ltd stocks hitting a 52-week low?
Should investors buy Strides Pharma Science Ltd stocks when they hit a 52-week low?
How often should investors monitor the 52-week low of Strides Pharma Science Ltd stocks?
How can an investor assess the risk of buying Strides Pharma Science Ltd stock at their 52-week low?
Should investors consider the overall market trend when evaluating Strides Pharma Science Ltd stocks at their 52-week low?
Unlimited trading at just
Rs. 199*